Status:
COMPLETED
Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals
Lead Sponsor:
The Alfred
Collaborating Sponsors:
Cellestis
Conditions:
HIV Infection
CMV Infection
Eligibility:
All Genders
18+ years
Brief Summary
The study is designed to evaluate interferon responses to CMV in HIV positive individuals and a component will look at interferon responses to CMV in HIV positive individuals over time after commencem...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- HIV positive with history of documented HCV infection
- Over 18 years old
- HIV positive
- Antiretroviral naive, starting on antiretroviral therapy
Exclusion
Key Trial Info
Start Date :
December 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00168259
Start Date
December 1 2004
End Date
December 1 2009
Last Update
January 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alfred Hospital
Melbourne, Victoria, Australia, 3004